Related Experiment Videos
Austrian report on longitudinal outcome in phenylketonuria
S Scheibenreiter1, M Tiefenthaler, V Hinteregger
1University Children's Hospital, Vienna, Austria.
European Journal of Pediatrics
|July 1, 1996
Summary
Austrian children with phenylketonuria (PKU) and hyperphenylalaninaemia (HPA) show normal intellectual development due to strict dietary management. However, IQ alone doesn't guarantee dietary compliance, highlighting the need for ongoing patient support.
Area of Science:
- Metabolic disorders
- Pediatric neurology
- Nutritional science
Background:
- Phenylketonuria (PKU) and hyperphenylalaninaemia (HPA) are genetic metabolic disorders requiring lifelong management.
- Effective treatment, initiated by Horst Bickel, relies heavily on early and consistent dietary control.
Purpose of the Study:
- To evaluate the current treatment status and outcomes of Austrian children with PKU and HPA.
- To assess the correlation between intellectual development and dietary adherence in these patients.
Main Methods:
- Investigated 70 children (60 PKU, 10 HPA) aged 6-16 years for somatic and intellectual parameters.
- Compared IQ data of PKU patients with their healthy siblings at age 6.
- Analyzed factors influencing intellectual outcomes in PKU patients.
Main Results:
- Austrian PKU and HPA patients exhibit normal intellectual development (mean IQs 95.40 and 101.85, respectively) due to strict dietary control, particularly in early childhood.
- Significant correlations were observed between IQ measurements and healthy siblings at age 6.
- Normal IQ values do not solely guarantee the quality of dietary control, as IQ is multifactorial.
Conclusions:
- While Austrian PKU patients achieve normal IQs, this metric is insufficient to confirm optimal dietary adherence.
- Maintaining and improving dietary compliance necessitates comprehensive patient and family education and robust psychosocial support.
- Ongoing informative counseling is crucial for long-term management of PKU and HPA.